New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15051366
Abstract: The combination of one molecule of organic and metal-based fragments that exhibit antitumor activity is a modern approach in the search for new promising drugs. In this work, biologically active ligands based on lonidamine (a… read more here.
Keywords: motif antitumor; lonidamine motif; antitumor; organometallic compounds ... See more keywords